Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94700096 | 9470009 | 6 | F | 200903 | 20160815 | 20130822 | 20160822 | EXP | JP-JNJFOC-20130809040 | JANSSEN | 32.32 | YR | A | M | Y | 0.00000 | 20160822 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94700096 | 9470009 | 1 | PS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | N | 21976 | 1200 | MG | TABLETS | QD | ||||||
| 94700096 | 9470009 | 2 | SS | EMTRICITABINE W/TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINETENOFOVIR DISOPROXIL | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 94700096 | 9470009 | 3 | SS | NORVIR | RITONAVIR | 1 | Oral | 0 | 200 | MG | UNSPECIFIED | QD | |||||||
| 94700096 | 9470009 | 4 | C | ZETIA | EZETIMIBE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 94700096 | 9470009 | 5 | C | TAKEPRON | LANSOPRAZOLE | 1 | Oral | 0 | 15 | MG | SUSTAINED RELEASE TABLETS | QD | |||||||
| 94700096 | 9470009 | 6 | C | TAKEPRON | LANSOPRAZOLE | 1 | Oral | 0 | 30 | MG | SUSTAINED RELEASE TABLETS | QD | |||||||
| 94700096 | 9470009 | 7 | C | MUCOSTA | REBAMIPIDE | 1 | Oral | 0 | 100 | MG | TABLET | BID | |||||||
| 94700096 | 9470009 | 8 | C | MUCOSTA | REBAMIPIDE | 1 | Oral | 0 | 100 | MG | TABLET | TID | |||||||
| 94700096 | 9470009 | 9 | C | LIMAS | LITHIUM CARBONATE | 1 | Oral | 0 | 200 | MG | TABLET | BID | |||||||
| 94700096 | 9470009 | 10 | C | BEZATOL SR | BEZAFIBRATE | 1 | Oral | 0 | 200 | MG | SUSTAINED RELEASE TABLETS | BID | |||||||
| 94700096 | 9470009 | 11 | C | BONOTEO | MINODRONIC ACID | 1 | Oral | 0 | 50 | MG | TABLET | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 94700096 | 9470009 | 1 | HIV infection |
| 94700096 | 9470009 | 2 | HIV infection |
| 94700096 | 9470009 | 3 | HIV infection |
| 94700096 | 9470009 | 4 | Dyslipidaemia |
| 94700096 | 9470009 | 5 | Gastrooesophageal reflux disease |
| 94700096 | 9470009 | 6 | Gastrooesophageal reflux disease |
| 94700096 | 9470009 | 7 | Gastrooesophageal reflux disease |
| 94700096 | 9470009 | 8 | Gastrooesophageal reflux disease |
| 94700096 | 9470009 | 9 | Bipolar disorder |
| 94700096 | 9470009 | 10 | Dyslipidaemia |
| 94700096 | 9470009 | 11 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 94700096 | 9470009 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 94700096 | 9470009 | Gastritis | |
| 94700096 | 9470009 | Gastrooesophageal reflux disease | |
| 94700096 | 9470009 | Osteopenia | |
| 94700096 | 9470009 | Osteoporosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 94700096 | 9470009 | 1 | 20080118 | 0 | ||
| 94700096 | 9470009 | 2 | 20080118 | 0 | ||
| 94700096 | 9470009 | 3 | 20080118 | 0 | ||
| 94700096 | 9470009 | 4 | 20130725 | 0 | ||
| 94700096 | 9470009 | 5 | 20100626 | 20110209 | 0 | |
| 94700096 | 9470009 | 6 | 20110210 | 0 | ||
| 94700096 | 9470009 | 7 | 20121205 | 20140520 | 0 | |
| 94700096 | 9470009 | 8 | 20100903 | 20121204 | 0 | |
| 94700096 | 9470009 | 9 | 20110506 | 0 | ||
| 94700096 | 9470009 | 10 | 20110511 | 0 | ||
| 94700096 | 9470009 | 11 | 20130404 | 20160323 | 0 |